ENTRY       D12429                      Drug
NAME        Surzebiclimab (USAN/INN)
FORMULA     C6428H9986N1716O2009S42
EXACT_MASS  144706.0262
MOL_WEIGHT  144795.0902
SEQUENCE    (Heavy chain)
            EVQLVESGGG LVQPGGSLRL SCAASGFTFS RYAMSWVRQA PGKGLEWVAA ISSGGSLYYP
            DSVKGRFTIS RDNAKNTLYL QMNSLRAEDT AVYYCARGRE ADGGYFDYWG QGTLVTVSSA
            STKGPSVFPL APSSKSTSGG TAALGCLVKD YFPEPVTVSW NSGALTSGVH TFPAVLQSSG
            LYSLSSVVTV PSSSLGTQTY ICNVNHKPSN TKVDKKVEPK SCDKTHTCPP CPAPPAAGPS
            VFLFPPKPKD TLMISRTPEV TCVVVDVSHE DPEVKFNWYV DGVEVHNAKT KPREEQYNST
            YRVVSVLTVL HQDWLNGKEY KCKVSNKALA APIEKTISKA KGQPREPQVY TLPPSRDELT
            KNQVSLTCLV KGFYPSDIAV EWESNGQPEN NYKTTPPVLD SDGSFFLYSK LTVDKSRWQQ
            GNVFSCSVMH EALHNHYTQK SLSLSPGK
            (Light chain)
            EIVLTQSPAT LSVSPGERAT LSCRASESVE YYGTSLMQWY QQKPGQAPRL LIYAASNVES
            GIPARFSGSG SGTEFTLTIS SLQSEDFAVY YCQQSLKVPL TFGGGTKVEI KRTVAAPSVF
            IFPPSDEQLK SGTASVVCLL NNFYPREAKV QWKVDNALQS GNSQESVTEQ DSKDSTYSLS
            STLTLSKADY EKHKVYACEV THQGLSSPVT KSFNRGEC
            (Disulfide bridge: H22-H95, H146-H202, H222-L218, H231-H'231, H262-H322, H368-H426, H'22-H'95, H'146-H'202, H'222-L'218, H'262-H'322, H'368-H'426, L23-L92, L138-L198, L'23-L'92, L'138-L'198)
  TYPE      Peptide
EFFICACY    Antineoplastic
  TYPE      Monoclonal antibody
TARGET      HAVCR2 (CD366) [HSA:84868] [KO:K20414]
BRITE       Target-based classification of drugs [BR:br08310]
             Cell surface molecules and ligands
              Other cell surface molecules
               CD molecules
                HAVCR2 (CD366)
                 D12429  Surzebiclimab (USAN/INN)
DBLINKS     CAS: 2342597-90-2
///
